Index Pharmaceuticals

DNA-based immunomodulatory sequence medication for the treatment of inflammtatory bowel disease.

placeStockholm, Stockholm County, Sweden calendar_todayFounded 2000 groups7 employees language indexpharma.com

Registered entities

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital571%
Accelerator & incubator114%
Other / undisclosed114%
Coming soon